|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.81 CNY | +1.59% |
|
+0.22% | -4.41% |
| 05-14 | Enwei Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023 | CI |
| 04-21 | Enwei Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Enwei Pharmaceutical Co., Ltd. (SZSE:301331) announces a share repurchase program. Under the program, the company will repurchase up to CNY 150 million worth of its shares. The shares will be repurchased at a price not more than CNY 63.41 per share.
The repurchased shares will be used for ESOP or equity incentives. The repurchase period will be not more than 12 months.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.41% | 370M | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| -5.52% | 206B | |
| +6.17% | 164B | |
| -0.45% | 162B |
ENWEI PHARMACEUTICAL CO., LTD. 
